173 related articles for article (PubMed ID: 38403918)
1. S100A8-enriched microglia populate the brain of tau-seeded and accelerated aging mice.
Gruel R; Bijnens B; Van Den Daele J; Thys S; Willems R; Wuyts D; Van Dam D; Verstraelen P; Verboven R; Roels J; Vandamme N; Mancuso R; Pita-Almenar JD; De Vos WH
Aging Cell; 2024 May; 23(5):e14120. PubMed ID: 38403918
[TBL] [Abstract][Full Text] [Related]
2. Partial reduction of microglia does not affect tau pathology in aged mice.
Bennett RE; Bryant A; Hu M; Robbins AB; Hopp SC; Hyman BT
J Neuroinflammation; 2018 Nov; 15(1):311. PubMed ID: 30413160
[TBL] [Abstract][Full Text] [Related]
3. Regional vulnerability and spreading of hyperphosphorylated tau in seeded mouse brain.
Detrez JR; Maurin H; Van Kolen K; Willems R; Colombelli J; Lechat B; Roucourt B; Van Leuven F; Baatout S; Larsen P; Nuydens R; Timmermans JP; De Vos WH
Neurobiol Dis; 2019 Jul; 127():398-409. PubMed ID: 30878534
[TBL] [Abstract][Full Text] [Related]
4. Microglial activation in brain lesions with tau deposits: comparison of human tauopathies and tau transgenic mice TgTauP301L.
Sasaki A; Kawarabayashi T; Murakami T; Matsubara E; Ikeda M; Hagiwara H; Westaway D; George-Hyslop PS; Shoji M; Nakazato Y
Brain Res; 2008 Jun; 1214():159-68. PubMed ID: 18457819
[TBL] [Abstract][Full Text] [Related]
5. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.
Maphis N; Xu G; Kokiko-Cochran ON; Jiang S; Cardona A; Ransohoff RM; Lamb BT; Bhaskar K
Brain; 2015 Jun; 138(Pt 6):1738-55. PubMed ID: 25833819
[TBL] [Abstract][Full Text] [Related]
6. Accelerated aging exacerbates a pre-existing pathology in a tau transgenic mouse model.
Bodea LG; Evans HT; Van der Jeugd A; Ittner LM; Delerue F; Kril J; Halliday G; Hodges J; Kiernan MC; Götz J
Aging Cell; 2017 Apr; 16(2):377-386. PubMed ID: 28160413
[TBL] [Abstract][Full Text] [Related]
7. Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies.
Mewes A; Franke H; Singer D
PLoS One; 2012; 7(9):e45017. PubMed ID: 22984603
[TBL] [Abstract][Full Text] [Related]
8. THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency.
Vautheny A; Duwat C; Aurégan G; Joséphine C; Hérard AS; Jan C; Mitja J; Gipchtein P; Gaillard MC; Buée L; Blum D; Hantraye P; Bonvento G; Brouillet E; Cambon K; Bemelmans AP
Neurobiol Dis; 2021 Jul; 155():105398. PubMed ID: 34019997
[TBL] [Abstract][Full Text] [Related]
9. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy.
Joly-Amado A; Hunter J; Quadri Z; Zamudio F; Rocha-Rangel PV; Chan D; Kesarwani A; Nash K; Lee DC; Morgan D; Gordon MN; Selenica MB
Front Immunol; 2020; 11():997. PubMed ID: 32508844
[TBL] [Abstract][Full Text] [Related]
10. Implication of JNK pathway on tau pathology and cognitive decline in a senescence-accelerated mouse model.
Orejana L; Barros-Miñones L; Aguirre N; Puerta E
Exp Gerontol; 2013 Jun; 48(6):565-71. PubMed ID: 23501261
[TBL] [Abstract][Full Text] [Related]
11. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model.
Shi Y; Manis M; Long J; Wang K; Sullivan PM; Remolina Serrano J; Hoyle R; Holtzman DM
J Exp Med; 2019 Nov; 216(11):2546-2561. PubMed ID: 31601677
[TBL] [Abstract][Full Text] [Related]
12. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
[TBL] [Abstract][Full Text] [Related]
13. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease.
Sobue A; Komine O; Hara Y; Endo F; Mizoguchi H; Watanabe S; Murayama S; Saito T; Saido TC; Sahara N; Higuchi M; Ogi T; Yamanaka K
Acta Neuropathol Commun; 2021 Jan; 9(1):1. PubMed ID: 33402227
[TBL] [Abstract][Full Text] [Related]
14. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
15. Intersection of pathological tau and microglia at the synapse.
Vogels T; Murgoci AN; Hromádka T
Acta Neuropathol Commun; 2019 Jul; 7(1):109. PubMed ID: 31277708
[TBL] [Abstract][Full Text] [Related]
16. Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.
Vega IE; Umstead A; Wygant CM; Beck JS; Counts SE
Curr Alzheimer Res; 2018; 15(12):1086-1095. PubMed ID: 30101710
[TBL] [Abstract][Full Text] [Related]
17. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.
Shi Y; Yamada K; Liddelow SA; Smith ST; Zhao L; Luo W; Tsai RM; Spina S; Grinberg LT; Rojas JC; Gallardo G; Wang K; Roh J; Robinson G; Finn MB; Jiang H; Sullivan PM; Baufeld C; Wood MW; Sutphen C; McCue L; Xiong C; Del-Aguila JL; Morris JC; Cruchaga C; ; Fagan AM; Miller BL; Boxer AL; Seeley WW; Butovsky O; Barres BA; Paul SM; Holtzman DM
Nature; 2017 Sep; 549(7673):523-527. PubMed ID: 28959956
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.
Ishikawa A; Tokunaga M; Maeda J; Minamihisamatsu T; Shimojo M; Takuwa H; Ono M; Ni R; Hirano S; Kuwabara S; Ji B; Zhang MR; Aoki I; Suhara T; Higuchi M; Sahara N
J Alzheimers Dis; 2018; 61(3):1037-1052. PubMed ID: 29332041
[TBL] [Abstract][Full Text] [Related]
19. The NLRP3 inflammasome modulates tau pathology and neurodegeneration in a tauopathy model.
Stancu IC; Lodder C; Botella Lucena P; Vanherle S; Gutiérrez de Ravé M; Terwel D; Bottelbergs A; Dewachter I
Glia; 2022 Jun; 70(6):1117-1132. PubMed ID: 35174546
[TBL] [Abstract][Full Text] [Related]
20. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.
Koller EJ; Gonzalez De La Cruz E; Machula T; Ibanez KR; Lin WL; Williams T; Riffe CJ; Ryu D; Strang KH; Liu X; Janus C; Golde TE; Dickson D; Giasson BI; Chakrabarty P
Hum Mol Genet; 2019 Oct; 28(19):3255-3269. PubMed ID: 31261380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]